Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02796014|
Recruitment Status : Completed
First Posted : June 10, 2016
Last Update Posted : August 21, 2017
The Dermatological Diseases Family Impact Scale (DeFIS) was developed to assess different aspects of health-related quality of life in the relatives of the patients with various skin diseases. The preliminary validation of this instrument was performed for the Turkish population. In the pilot study, this 15-item-questionnaire was shown to be easy to complete and score, and reliably help to evaluate the family members' quality of life.
Psoriasis is a chronic disease which can be expected to have a significant impact on the quality of life of the patients and parents/family members alike. In line with this assumption, previous studies demonstrated that psoriasis psychosocially affects not only the patients, but also their close relatives. The psoriasis family index has been developed in an effort to objectively measure the health-related quality of life of the family members of patients with psoriasis. Nevertheless, data regarding the health-related quality of life of the parents of pediatric patients with psoriasis in the Turkish population are relatively scarce.
In study, the investigators primarily aim to utilize DeFIS to assess the impact of childhood psoriasis on the quality of life of the patients' parents. Further, the investigators attempt to investigate the relation between the quality of life of the patients and their parents, and reveal disease characteristics which might influence the quality of life.
|Condition or disease|
|Psoriasis Quality of Life|
|Study Type :||Observational|
|Actual Enrollment :||129 participants|
|Official Title:||Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis, and Comparison of This Scale With the Children's Dermatology Life Quality Index and Disease Severity|
|Study Start Date :||May 2016|
|Actual Primary Completion Date :||March 2017|
|Actual Study Completion Date :||March 2017|
- Assessment of the impact of childhood psoriasis on the parents of the patients using the Dermatological Diseases Family Impact Scale [ Time Frame: 6 months ]
- Comparison of the quality of life of the parents (as evaluated using the Dermatological Diseases Family Impact Scale) with the quality of life of the patients (as assessed using the Children's Dermatology Life Quality Index) [ Time Frame: 6 months ]
- Delineating disease characteristics which influence the patients' and/or their parents' health-related quality of life [ Time Frame: 6 months ]Disease characteristics such as age of onset, disease subtype, psoriasis area and severity index and scalp involvement will be recorded. The impact of these parameters on quality of life will be assessed using statistical methods.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02796014
|Istanbul Medeniyet University Goztepe Research and Training Hospital|
|Istanbul, Kadikoy, Turkey, 34720|
|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|
|Haseki Training and Research Hospital|
|Haydarpasa Numune Training and Research Hospital|
|Istanbul Training and Research Hospital|
|Okmeydani Training and Research Hospital|
|Sisli Etfal Training & Research Hospital|
|Principal Investigator:||Burak Tekin, M.D.||Istanbul Medeniyet University Goztepe Research and Training Hospital Department of Dermatology|